Design of large-scale manufacturing of induced pluripotent stem cell derived cardiomyocytes

Chemical Engineering Research and Design

Volumn 92, Issue 6, 2014, Pages 1142-1152

  Darkins, Christopher Luke ^a,b   Mandenius, Carl Fredrik ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Biomechatronics; CAD; Cardiomyocytes; Conceptual design; IPSC; Pluripotent stem cells

Indexed keywords

CONCEPTUAL DESIGN; MANUFACTURE; STEM CELLS;

BIO-MECHATRONICS; CARDIOMYOCYTES; EQUIPMENT CONFIGURATION; HUMAN-INDUCED PLURIPOTENT STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; IPSC; LARGE-SCALE MANUFACTURING; PLURIPOTENT STEM CELLS;

COMPUTER AIDED DESIGN;

EID: 84901639180     PISSN: 02638762     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cherd.2013.08.021     Document Type: Article

References (50)

1. Archer R., Williams D.J. Why tissue engineering needs process engineering?. Nat. Biotechnol. 2005, 23:1353-1355.
2. Braam S.R., Passier R., Mummery C.L. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol. Sci. 2009, 30:536-545.
3. Burridge W.P., Thompson S., Millrod M.A., Weinberg S., Yuan X., Peters A., Mahairaki V.E., Koliatsos V.E., Tung L., Zambidis E.T. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 2011, 6(4):e18293.
4. Cabral J.M.S. Cell partitioning ion aqueous two-phase polymer systems. Adv. Biochem. Eng. Biotechnol. 2007, 106:151-171.
5. Chen Q.Z., Harding S.E., Ali N.N., Lyon A.R., Boccaccini A.R. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater. Sci. Eng., R 2008, 59:1-37.
6. Dainiak M.B., Kumar A., Galaev I.Y., Mattiasson B. Methods in cell separations. Adv. Biochem. Eng. Biotechnol. 2007, 106:1-18.
7. De Napoli I.E., Scaglione S., Giannoni P., Quarto R., Catapano G. Mesenchymal stem cell culture in convection-enhanced hollow fibre membrane bioreactors for bone tissue engineering. J. Membr. Sci. 2011, 379:341-352.
8. Derelöv M., Detterfelt J., Björkman M., Mandenius C.F. Engineering design methodology for bio-mechatronic products. Biotechnol. Prog. 2008, 24:232-244.
9. Eibl R., Kaiser S., Lombriser R., Eibl D. Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology. Appl. Microbiol. Biotechnol. 2010, 86:41-49.
10. Flanagan L.A., Lu J., Wang L., Marchenko S.A., Li Jeon N., Lee A.P., et al. Unique dielectric properties distinguish stem cells and their differentiated progeny. Stem Cells 2008, 26:656-665.
11. Freshney R.I. Culture of Animal Cells 2005, Wiley and Sons, Inc., Hoboken, NJ, USA.
12. Gonzalez-Gonzales M., Vazquez-Villegas P., Garcia-Salinas C., Rito-Palomares M. Current strategies and challenges for the purification of stem cells. J. Chem. Technol. Biotechnol. 2012, 87:2-10.
13. Harrison R.G., Todd P., Rudge S.R., Petrides D.P. Bioseparations Science and Engineering 2003, Oxford University Press, Inc., New York.
14. Heinzle E., Biwer A.P., Cooney C.L. Development of Sustainable Bioprocesses: Modelling and Assessment 2007, John Wiley and Sons, Inc., Hoboken, NJ, USA.
15. Huang G.T.J. Induced pluripotent stem cells: a new foundation in medicine. J. Exp. Clin. Med. 2010, 2:202-217.
16. Hubka V., Eder W.E. Design Science 1996, Springer Verlag, Berlin, Germany.
17. Jensen J., Hyllner J., Björquist P. Human embryonic stem cell technology and drug discovery. J. Cell. Physiol. 2009, 219:513-519.
18. Kamihira M., Kumar A. Development of separation technique for stem cells. Adv. Biochem. Eng. Biotechnol. 2007, 106:173-193.
19. Kane M.N., Xiao Q., Baker A.H., Luo Z., Xu Q., Emanueli C. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular regeneration. Pharmacol. Ther. 2011, 129:29-49.
20. Kumar A., Kamihira M., Galaev I.Y., Mattiasson B., Iijima S. Typespecific separation of animal cells in aqueous two-phase systems using antibody conjugates with temperature-sensitive polymers. Biotechnol. Bioeng. 2001, 75:570-580.
21. Lara O., Tong X., Zborowski M., Farag S.S., Chalmers J.J. Comparison of two immunomagnetic separation technologies to deplete T cells from human blood. Biotechnol. Bioeng. 2006, 94:66-80.
22. Lei X.H., Ning L.N., Cao Y.J., Liu S., Zhang S.B., et al. NASA-approved rotary bioreactor enhances proliferation of human epidermal stem cells and supports formation of 3D epidermis-like structure. PLoS ONE 2011, 6(11):e26603.
23. Mahara A., Yamaoka T. Continuous separation of cells of high osteoblastic differentiation potential from mesenchymal stem cells on an antibody-immobilized column. Biomaterials 2010, 31:4231-4237.
24. Mandenius C.F. Biomechatronics for designing bioprocess monitoring and control systems: application to stem cell production. J. Biotechnol. 2012, 162:430-440.
25. Mandenius C.F., Björkman M. Process analytical technology (PAT) and quality-by-design (QbD) aspects on stem cell manufacture. Eur. Pharm. Rev. 2009, 14(1):32-37.
26. Mandenius C.F., Björkman M. Design principles for biotechnology product development. Trends Biotechnol. 2010, 28:230-236.
27. Mandenius C.F., Björkman M. Biomechatronic Design in Biotechnology: A Methodology for Development of Biotechnological Products 2011, John Wiley & Sons, Inc., Hoboken, NJ, USA.
28. Mandenius C.F., Björkman M. Scale-up of bioreactors using biomechantronic design methodology. Biotechnol. J. 2012, 7(8):1026-1039.
29. Mandenius C.F., Steel D., Noor F., Meyer T., Heinzle E., Asp J., Arain S., Kraushaar U., Bremer S., Class R., Sartipy S. Cardiotoxicity testing using pluripotent stem cell derived human cardiomyocytes and state-of-the-art bioanalytics: a review. J. Appl. Toxicol. 2011, 31:191-205.
30. Mandenius C.F., Andersson T.B., Alves P.M., Batzl-Hartmann C., Björquist P., Carrondo M.J.T., Chesne C., Coecke S., Edsbagge J., Fredriksson J.M., Gerlach J.C., Heinzle E., Ingelman-Sundberg M., Johansson I., Küppers-Munther B., Müller-Vieira U., Noor F., Zeilinger K. Towards preclinical predictive drug testing for metabolism and hepatotoxicity by in vitro models derived from human embryonic stem cells: a report on the Vitrocellomics EU-project. Altern. Lab. Anim. (ATLA) 2011, 39(2):147-171.
31. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 2012, 111:344-358.
32. Olmer R., Lange A., Selzer S., Kasper C., Haverich A., Martin U., Zweigerdt R. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng. C 2012, 18.
33. Ostwald P.F. Engineering Cost Estimation 1992, Prentice Hall, Englewood Cliffs, NJ, USA. third ed.
34. Pahl G., Beitz W. Engineering Design: A Systematic Approach 1996, Springer Verlag, Berlin, Germany.
35. Ratcliffe E., Thomas R.J., Williams D.J. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine. Br. Med. Bull. 2011, 100:137-155.
36. Roda B., Reschiglian P., Alviano F., Lanzoni G., Bagnara G.P., Ricci F., et al. Gravitational field-flow fractionation of human hemopoietic stem cells. J. Chromatogr. A 2009, 1216:9081-9087.
37. Rouf S.A., Douglas P.L., Moo-Young M., Scharer J.M. Computer simulation for large scale bioprocess design. Biochem. Eng. J. 2001, 8:229-234.
38. Schriebl K., Lim S., Choo A., Tscheliessnig A., Jungbauer A. Stem cell separation: a bottleneck in stem cell therapy. Biotechnol. J. 2010, 5:50-61.
39. Schroeder M., Niebruegge S., Andreas Werner A., Willbold E., Burg M., Manfred Ruediger M., Field L.J., Lehmann J., Zweigerdt R. Differentiation and lineage selection of mouse embryonic stem cells in stirred bench scale bioreactor with automated process control. Biotechnol. Bioeng. 2005, 92:920-993.
40. Shanklin T., Roper K., Yegneswaran P.K., Marten M.R. Selection of bioprocess simulation software for industrial applications. Biotechnol. Bioeng. 2001, 72:483-489.
41. Singh V. Disposable bioreactor for cell culture using wave induced agitation. Cytotechnology 1999, 30:149-158.
42. Thomas R.J., Hourd P.C., Williams D.J. Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. J. Biotechnol. 2008, 136:148-155.
43. Thomas R.J., Anderson D., Chandra A., Smith N.M., Young L.E., Williams D., Denning C. Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol. Bioeng. 2009, 102:1636-1644.
44. Embryonic Stem cells, Methods and Protocols, Methods in Molecular Biology 2002, Humana Press, Inc, Totowa, NJ, (USA). K. Turksen (Ed.).
45. Ulrich K.T., Eppinger S.D. Product Design and Development 2007, McGraw-Hill, New York. third ed.
46. Wang X.B., Yang J., Huang Y., Vykoukal J., Becker F.F., Gascoyne P.R. Cell separation by dielectrophoretic field-flow-fractionation. Anal. Chem. 2000, 72:832-839.
47. Want A.J., Nienow A.W., Hewitt C.J., Coopman K. Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask. Reg. Med. 2012, 7:71-84.
48. Wu K.H., Mo X.M., Liu Y.L., Zhang Y.S., Han Z.C. Stem cells for tissue engineering of myocardial contructs. Ageing Res. Rev. 2007, 6:289-301.
49. Zoro B.J.H., Owen S., Drake R.A.L., Mason C., Hoare M. Regerantive medicine bioprocessing: concentration and behaviour of adherent cell suspensions and pastes. Biotechnol. Bioeng. 2009, 103:1236-1247.
50. Zweigerdt R., Olmer R., Singh H., Haverich A., Martin U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 2011, 6:689-700.